News
Cartesian Therapeutics, Inc.’s RNAC share price has dipped by 5.62%, which has investors questioning if this is right time to ...
Cartesian Therapeutics, Inc.’s RNAC share price has surged by 21.84%, which has investors questioning if this is right time to sell.
This month, there are many bargains on the finer things in life, Viking cutlery, imported chocolate, fresh sashimi, and even Sephora-worthy products including La Mer and Vacation Sunscreen. We did the ...
In a report released yesterday, Uy Ear from Mizuho Securities maintained a Buy rating on Cartesian Therapeutics (RNAC – Research Report), with a price target of $40.00. The company’s shares ...
(NEXSTAR) — If you purchased any Boar’s Head products that were later impacted by a widespread recall brought on by a deadly listeria outbreak last summer, you may be eligible to receive a ...
Claim your 7-day free trial now. Cartesian Therapeutics, Inc. RNAC on Tuesday revealed 12-month efficacy and safety data from the Phase 2b trial of Descartes-08, lead cell therapy candidate ...
Shares of Cartesian Therapeutics climbed after the company announced positive results in a phase 2b trial of its lead cell-therapy candidate. The stock was up 8.3% to $15.60 in morning trading Tuesday ...
Cartesian Therapeutics (NASDAQ:RNAC), a clinical-stage biotechnology company advancing innovative cell therapies for autoimmune diseases, unveiled encouraging 12-month efficacy and safety results from ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...
A veteran of the Canadian Armed Forces, he is one of a growing number of people in Canada, Europe, and other parts of the world, who are avoiding buying US products due to President Trump's ...
(AP Photo/Jon Cherry) The National Weather Service is no longer providing language translations of its products, a change that experts say could put non-English speakers at risk of missing potentially ...
Investing.com -- Nvidia’s AI server products are likely exempt from the latest round of U.S. tariffs under the US-Mexico-Canada Agreement (USMCA), a potential relief amid broader investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results